Maxidex (Dexamethasone)

Maxidex is a corticosteroid eye preparation used to manage inflammatory conditions of the eye and related pathways.

• Post‑operative ocular inflammation: reduces swelling and pain after eye surgery.
• Anterior uveitis: controls intra‑ocular inflammation and prevents tissue damage.
• Allergic conjunctivitis: alleviates redness, itching and edema caused by allergic reactions.
• Corneal edema: decreases fluid accumulation and improves visual clarity.

• Dexamethasone binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and modulates gene transcription. This action suppresses the production of pro‑inflammatory cytokines, prostaglandins, and leukotrienes, while enhancing anti‑inflammatory proteins, thereby reducing ocular inflammation and immune activation.

Adverse ocular and systemic reactions may occur with topical dexamethasone use.

Common Side Effects

• Eye irritation or burning sensation.
• Transient blurred vision.
• Increased intra‑ocular pressure.
• Mild cataract formation with prolonged use.
• Conjunctival hyperemia.
• Temporary stinging on instillation.

Serious or Rare Side Effects

• Secondary ocular infection (bacterial, fungal, or viral).
• Severe elevation of intra‑ocular pressure leading to glaucoma.
• Delayed wound healing after ocular surgery.
• Systemic adrenal suppression with extensive use.
• Corneal ulceration or melting.
• Allergic hypersensitivity reactions (e.g., angioedema).

Before prescribing Maxidex, clinicians should consider several safety measures.

• Monitor intra‑ocular pressure: check regularly, especially in glaucoma patients.
• Use with caution in patients with a history of ocular infections.
• Avoid in active viral keratitis or herpetic eye disease.
• Do not combine with non‑steroidal anti‑inflammatory eye drops without supervision.
• Discontinue if signs of secondary infection appear.
• Store at room temperature: keep in the original container, protect from moisture and light.

Dexamethasone eye drops can interact with other ocular or systemic agents.

Major Interactions (Avoid)

• Systemic corticosteroids: may increase risk of systemic side effects.
• Potent CYP3A4 inhibitors (e.g., ketoconazole): can raise systemic dexamethasone levels.

Moderate Interactions (Monitor Closely):\n- Topical NSAID eye drops: heightened risk of corneal melting.

• Anticholinergic eye preparations: may exacerbate dry‑eye symptoms.
• Antiviral agents for herpes simplex: monitor for reduced antiviral efficacy.